No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer

BACKGROUND: Studies over the past 10 years strongly support an association between skeletal muscle mass (SMM) depletion and outcome in metastatic colorectal cancer (mCRC). Factors influencing SMM changes over time are, however, poorly studied. We analyzed the impact of SMM on overall survival and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoun, Sami, Bayar, Mohamed Amine, Dyevre, Valérie, Lanoy, Emilie, Smolenschi, Cristina, Ducreux, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714393/
https://www.ncbi.nlm.nih.gov/pubmed/31462288
http://dx.doi.org/10.1186/s12885-019-6086-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714393/
https://www.ncbi.nlm.nih.gov/pubmed/31462288
http://dx.doi.org/10.1186/s12885-019-6086-2

Ejemplares similares